Focus Stocks
Teva near Resistance
Published on Tuesday, 17 August 2010 06:12 Written by Christian Paolinetti
New York, August 17th (TradersHuddle.com) - Shares of Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) are trading very close to calculated resistance at $50.78 with the current price action closing at just $50.27 placing the stock near levels that make it difficult to buy.
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis.
Teva's current stock range is defined by current calculated support defined at $46.99 and by the resistance level at $50.78, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for Teva, as the stock is well above support, however, as the stock pulls back towards $46.99 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $50.78 then traders will get an opportunity to enter Teva stock by establishing a position as the stock moves to a higher range.
Related Articles
- Neutral Short Term Pattern on Teva
- ChromaDex Corp. Names Consumer Products Veteran Jeffrey Himmel CEO
- Teva to Report Fourth Quarter and Full Year 2011 Financial Results on February 15, 2012
- Teva to Present at the 30th Annual J.P. Morgan Healthcare Conference
- Advanced Magnetic Resonance Imaging Technology Suggests Axonal Repair in Multiple Sclerosis Patients Treated with COPAXONE®
- Teva Announces Management Succession
- Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe
- Teva Lower With High Volume
- Teva Provides 2012 Non-GAAP Financial Outlook; 2012 Non-GAAP Diluted EPS of $5.48 to $5.68
- Teva Announces $3 billion Share Repurchase Program
Related Partner Headlines
- UPDATE: Morgan Stanley Downgrades Teva Pharmaceuticals to Equal-Weight - Benzinga
- Morgan Stanley Downgrades Teva Pharmaceutical to Equal-weight - Benzinga
- Teva Gets Upgrade on Revenue Growth - TheStreet.com
- Teva Pharmaceutical Industries Ltd Stock Upgraded (TEVA) - TheStreet.com
- Teva Taps Bristol-Myers' Levin as Next CEO - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Loser - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Winner - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Loser - TheStreet.com
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Health Care Winner - TheStreet.com
- Teva Stock To Go Ex-dividend Tomorrow (TEVA) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Technical Scans
-
Over Extended Stocks Above Resistance -
Stocks Near 50 and 200 Day Moving Average Bullish Configuration 50 Above 200 Day -
Near Both 50 and 200 Day - Stocks Trading Below 50 and Above the 200 Day -
Stocks Close to Resistance -
Stocks Near 50 and 200 Day Moving Average Trading Above Both Moving Averages - With 50 day below the 200
Recent Trading Ideas
Latest Partner Headlines
-
Top 4 Small-Cap Stocks In The Broadcasting-Radio Industry With The Highest Cash - Benzinga -
Top 4 Stocks In The Textile Industrial Industry With The Lowest PEG Ratio - Benzinga -
Top 4 Stocks In The Cleaning Products Industry With The Highest Operating Margin - Benzinga -
Earnings Scheduled For February 9 - Benzinga -
Stocks To Watch For February 9 - Benzinga -
Benzinga's Microcap Movers for Wednesday February 8, 2012 - Benzinga -
Five More Stocks ETFs Need More Of - Benzinga -
ETFs to Watch February 9, 2012 - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:▲2.91 (0.22%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:▲11.78 (0.41%)In The Wires
-
BRAVADA CEO Danny Alex Says “BRAVADA International Ltd. Sets a New Standard for Microcap Companies in Creating Real Growth, Real Value and Real Return on Investment Despite the Worst Economy Since the Great Depression” -
Nujira Selects TowerJazz as Foundry Partner for New Envelope Tracking IC -
/C O R R E C T I O N -- Daimler Corporate Communications/ -
RDA Microelectronics Announces Fourth Quarter and Full Year 2011 Financial Results -
Forum Subsea Technologies Wins Agreement With DOF Subsea for the Supply of Six Perry(TM) XLX ROV Systems -
StreamWIDE Enables Carriers to Run Value-Added Telephony Services on Amazon Web Services -
Forum Subsea Technologies Announces the Appointment of Two Senior Management Positions -
Citi California Pulse® Survey Finds Nearly Half of Californians Believe 2012 will be Better than 2011










